Elixir Capital Ltd
Incorporated in 1994, Elixir Capital Ltd is in the business of investing in shares and securities and of providing services of capital market research and analysis[1]
- Market Cap ₹ 72.6 Cr.
- Current Price ₹ 125
- High / Low ₹ 144 / 78.1
- Stock P/E 101
- Book Value ₹ 32.4
- Dividend Yield 0.99 %
- ROCE 3.85 %
- ROE 3.85 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 92.9%
Cons
- Stock is trading at 3.70 times its book value
- The company has delivered a poor sales growth of -7.87% over past five years.
- Company has a low return on equity of 3.62% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Finance Other Financial Services
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.84 | 1.58 | 0.10 | 0.78 | 0.78 | 0.76 | 1.13 | 1.49 | 1.35 | 0.90 | 0.92 | 0.75 | |
| 0.11 | 0.15 | 0.09 | 0.10 | 0.11 | 0.12 | 0.11 | 0.10 | 0.13 | 0.18 | 0.28 | 0.18 | |
| Operating Profit | 0.73 | 1.43 | 0.01 | 0.68 | 0.67 | 0.64 | 1.02 | 1.39 | 1.22 | 0.72 | 0.64 | 0.57 |
| OPM % | 86.90% | 90.51% | 10.00% | 87.18% | 85.90% | 84.21% | 90.27% | 93.29% | 90.37% | 80.00% | 69.57% | 76.00% |
| 0.02 | 0.28 | 0.03 | 0.03 | 0.03 | 0.04 | 0.01 | 0.02 | 0.04 | 0.54 | 0.00 | 0.15 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.74 | 1.70 | 0.04 | 0.71 | 0.70 | 0.68 | 1.03 | 1.41 | 1.26 | 1.26 | 0.64 | 0.72 |
| Tax % | 0.00% | 2.35% | 25.00% | -1.41% | 0.00% | 1.47% | 0.97% | 10.64% | 10.32% | 10.32% | 0.00% | 0.00% |
| 0.74 | 1.66 | 0.03 | 0.71 | 0.69 | 0.66 | 1.01 | 1.25 | 1.13 | 1.12 | 0.64 | 0.72 | |
| EPS in Rs | 1.28 | 2.86 | 0.05 | 1.22 | 1.19 | 1.14 | 1.74 | 2.15 | 1.95 | 1.93 | 1.10 | 1.24 |
| Dividend Payout % | 97.97% | 43.67% | 2,416.67% | 102.11% | 105.07% | 109.85% | 71.78% | 58.00% | 64.16% | 64.73% | 113.28% | 100.69% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -8% |
| 3 Years: | -18% |
| TTM: | -18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | -7% |
| 3 Years: | -14% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 17% |
| 3 Years: | 39% |
| 1 Year: | 8% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 5% |
| 3 Years: | 4% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 | 5.80 |
| Reserves | 10.39 | 11.32 | 10.62 | 11.34 | 11.30 | 11.24 | 11.52 | 12.05 | 12.45 | 12.85 | 12.76 | 13.03 |
| 0.11 | 0.00 | 0.00 | 0.01 | 0.03 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 0.80 | 0.08 | 0.81 | 0.09 | 0.11 | 0.09 | 0.09 | 0.09 | 0.09 | 0.11 | 0.04 | 0.04 | |
| Total Liabilities | 17.10 | 17.20 | 17.23 | 17.24 | 17.24 | 17.22 | 17.41 | 17.94 | 18.34 | 18.76 | 18.60 | 18.87 |
| 0.16 | 0.17 | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.14 | 0.14 | 0.01 | 0.01 | 0.01 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 16.88 | 17.01 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 | 16.88 |
| 0.06 | 0.02 | 0.19 | 0.20 | 0.20 | 0.19 | 0.38 | 0.92 | 1.32 | 1.87 | 1.71 | 1.98 | |
| Total Assets | 17.10 | 17.20 | 17.23 | 17.24 | 17.24 | 17.22 | 17.41 | 17.94 | 18.34 | 18.76 | 18.60 | 18.87 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.20 | 0.01 | -0.03 | -0.06 | -0.08 | 0.15 | 0.14 | 0.30 | -0.18 | -0.44 | 0.00 | |
| 0.75 | 1.36 | 0.13 | 0.76 | 0.78 | 0.82 | 0.66 | 0.79 | 0.80 | 0.27 | 1.20 | 0.00 | |
| -0.74 | -1.56 | 0.00 | -0.73 | -0.73 | -0.73 | -0.73 | -0.73 | -0.73 | -0.73 | -0.73 | 0.00 | |
| Net Cash Flow | 0.00 | 0.00 | 0.14 | 0.00 | -0.01 | 0.01 | 0.08 | 0.21 | 0.38 | -0.64 | 0.03 | 0.00 |
| Free Cash Flow | 0.00 | 0.19 | 0.01 | -0.03 | -0.06 | -0.08 | 0.15 | 0.14 | 0.30 | 0.47 | -0.44 | 0.00 |
| CFO/OP | 0% | 16% | 300% | -3% | -9% | -12% | 21% | 21% | 38% | -17% | -50% | 0% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 126.53 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 126.53 |
| Working Capital Days | -373.69 | -9.24 | -2,774.00 | -23.40 | -37.44 | -72.04 | 19.38 | 124.93 | 143.30 | 693.50 | 618.91 | 827.33 |
| ROCE % | 4.54% | 8.68% | 0.24% | 4.29% | 4.08% | 3.97% | 5.98% | 8.02% | 6.98% | 4.01% | 3.44% | 3.85% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees (Standalone) Number |
|
|||||||||
| Number of Subsidiaries Number |
||||||||||
| Trade Receivables Turnover Ratio (Consolidated) Ratio |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
1d - Enclosed is an intimation for allotment of shares on account of exercise of ESOPs and grant of fresh ESOPs
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Jun
-
Announcement under Regulation 30 (LODR)-Change in Management
29 May - Board approved FY26 audited results, 12.5% final dividend, and auditor/director reappointments on 29 May 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting
29 May - Board approved FY26 audited results, recommended 12.5% dividend, and reappointed/appointed directors and auditors.
-
Audited Annual Financial Results For The Financial Year Ended 31-Mar-2026
29 May - Board approved FY26 audited results, recommended 12.5% dividend, and reappointed directors and auditors.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
Company does trading and investment in shares and provides research services. It manages investment and trading portfolio focused on small and mid cap stocks